UNI-EN 60:Current report 60 Maritsateks_21062012 ЕNG
Firma: SOPHARMA ADSpis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Spis załączników:
| POLISH FINANCIAL SUPERVISION AUTHORITY | |||||||||||
| | UNI - EN REPORT No | 60 | / | 2012 | | ||||||
| Date of issue: | 2012-06-21 | ||||||||||
| Short name of the issuer | |||||||||||
| SOPHARMA AD | |||||||||||
| Subject | |||||||||||
| Current report 60 Maritsateks_21062012 ЕNG | |||||||||||
| Official market - legal basis | |||||||||||
| Art. 56 ust. 1 pkt 1 Ustawy o ofercie - informacje poufne | |||||||||||
| Unofficial market - legal basis | |||||||||||
| Contents of the report: | |||||||||||
| Current report No. 60 / 2012 Dated 21 June 2012 DISCLOSURE OF SHAREHOLDINGS The Board of Directors of Sopharma AD (the “Company") announces that: Sopharma AD, bought 6149 shares, representing 1,31% of the capital of Maritzatex AD and as a result of this transaction Sopharma AD has crossed the threshold of 5% of the capital of Maritzatex AD and now owns 6,01% of the capital of the latter. The date of registration of the transaction with the Central Depository is June 18, 2012. Legal grounds: Other regulations Signatures of individuals authorized to represent the Company: Ognian Donev | |||||||||||
| Annexes | |||||||||||
| File | Description | ||||||||||
| Current report 60 Maritsateks_21062012 ЕNG.doc Current report 60 Maritsateks_21062012 ЕNG.doc | Current report 60 Maritsateks_21062012 ЕNG | ||||||||||
| SOPHARMA AD | |||||||||||||
| (fullname of the issuer) | |||||||||||||
| SOPHARMA AD | Farmaceutyczny (far) | ||||||||||||
| (short name of the issuer) | (sector according to clasification of the WSE in Warsow) | ||||||||||||
| 1220 | Sofia | ||||||||||||
| (post code) | (city) | ||||||||||||
| IlienskoShosse | 16 | ||||||||||||
| (street) | (number) | ||||||||||||
| +359 2 813 42 00 | +359 2 936 02 86 | ||||||||||||
| (phone number) | (fax) | ||||||||||||
| (e-mail) | (web site) | ||||||||||||
| nd | |||||||||||||
| (NIP) | (REGON) | ||||||||||||
| SIGNATURE OF PERSONS REPRESENTING THE COMPANY | |||||
| Date | Name | Position / Function | Signature | ||
| 2012-06-21 | Ognian Donev | Executive Director | |||
Cena akcji Sopharma
Cena akcji Sopharma w momencie publikacji komunikatu to None PLN. Sprawdź ile kosztuje akcja Sopharma aktualnie.
W tej sekcji znajdziesz wszystkie komunikaty ESPI EBI Sopharma.
